{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:23:56Z","timestamp":1773152636303,"version":"3.50.1"},"reference-count":0,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1454,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>We examined the effect of growth hormone (GH) administration on the psychological capacity and sense of well\u2010being in 25 patients with adult\u2010onset GH\u2010deficiency (GHD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Very low dosages (0.5\u20131.0\u2003UI\u2003day<jats:sup>\u22121<\/jats:sup> s.c. at bed\u2010time) of recombinant human (rh)\u2010GH (<jats:italic>n<\/jats:italic>\u2003=\u200313; aged 50\u2003\u00b1\u200315 years, mean\u2003\u00b1\u2003SD) or placebo (<jats:italic>n<\/jats:italic>\u2003=\u200312, 53\u2003\u00b1\u200314 years) were given at random for a 6\u2010month period. Quality of life was assessed by using the Italian version of the self\u2010rating Kellner Symptom Questionnaire (KSQ) and the Hamilton Depression Scale (HDS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No difference in insulin\u2010like growth factor I (IGF\u2010I) levels was noted between groups on entry to the study. A significant increase in IGF\u2010I (month 0 56.2\u2003\u00b1\u200310.4\u2003\u03bcg\u2003L<jats:sup>\u22121<\/jats:sup> vs. month 6 125.7\u2003\u00b1\u200316.7\u2003\u03bcg\u2003L<jats:sup>\u22121<\/jats:sup>; <jats:italic>P\u2003<\/jats:italic>&lt;\u20030.001) levels was noted only in the rh\u2010GH\u2010treated group. There was no difference in overall scores on the KSQ between the rh\u2010GH\u2010treated and control groups on entry. A slight, non\u2010significant, decrease in overall scores was noted in both groups of subjects. Subsection analysis of items from the KSQ did not show significant differences in either group during the 6\u2010month period. A significant decrease (month 0 28\u2003\u00b1\u20031 vs. month 6 25\u2003\u00b1\u20031; <jats:italic>P\u2003<\/jats:italic>=\u20030.02) in the HDS score was noted in rh\u2010GH\u2010treated but not in placebo\u2010treated patients. There was a significant correlation (<jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub>, \u20130.56, <jats:italic>P\u2003<\/jats:italic>=\u20030.05) between increase in IGF\u2010I levels and decrease in HDS scores in rh\u2010GH treated patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The data demonstrate that low rh\u2010GH dosages significantly improve psychological profiles as rated by HDS evaluation in adult\u2010onset patients with GHD. On the other hand, a 6\u2010month period of treatment does not produce any significant differences in quality of life as measured by KSQ between treated patients and placebo controls.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2362.1998.00239.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T15:40:37Z","timestamp":1047397237000},"page":"13-19","source":"Crossref","is-referenced-by-count":21,"title":["Impact of recombinant human growth hormone treatment on psychological profiles in hypopituitary patients with adult\u2010onset growth hormone deficiency"],"prefix":"10.1111","volume":"28","author":[{"family":"Giusti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Meineri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Malagamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Cuttica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Fattacciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Menichini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Rasore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.1998.00239.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.1998.00239.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2362.1998.00239.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T10:24:07Z","timestamp":1698488647000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2362.1998.00239.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1046\/j.1365-2362.1998.00239.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2362.1998.00239.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}